Hope is on the horizon for patients living with chronic obstructive pulmonary disease (COPD). CHEST 2024 in Boston featured a session highlighting emerging bronchoscopic therapies.
On Sept 17, 2024, tobacco giant Philip Morris International (PMI) announced that it was selling Vectura at an enormous loss. Vectura, a pharmaceutical company that specialises in inhaled medicines for ...
Some of the nation's busiest hospitals - including Liverpool and Campbelltown - will be treating thousands more patients from ...
Some of the nation's busiest hospitals - including Liverpool and Campbelltown - will be treating thousands more patients from the comfort of their own ...
Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...
Symptoms and activity improved in patients with chronic obstructive pulmonary disease and type 2 inflammation.
Dr. Christopher Stanley will serve as president of the new nonprofit subsidiary headquartered in Troy, which employs 150.
Rural women with COPD face rising mortality rates, while urban women and men see declines. A new study highlights the social ...
Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.
As Hurricane Milton approaches the Gulf Coast, the American Lung Association has released critical health guidance for ...
Less frequent dosing could provide Eli Lilly’s Ebglyss room to rival Sanofi and Regeneron’s blockbuster Dupixent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback